Below is a self‑contained English “Methods”–style section you can use or adapt for an ICU research proposal or manuscript.
Methods: ICU Olfactory Field and Life‑Recall EEG Study
Study Rationale and Hypothesis
Continuous EEG recordings in dying patients have revealed brief, structured high‑frequency activity that may reflect “life‑recall–like” processing during the transition to brain death. The triggering mechanism of these events remains unknown. This study tests the hypothesis that exposure to a “postpartum olfactory field” – odor signatures originating from recently delivered mothers, their infants, or individuals who have been in close contact with them – facilitates a geometric “unlocking” of the olfactory bulb and increases the probability of life‑recall–like EEG patterns at the end of life.
Study Design
This will be a prospective, observational study conducted in one or more tertiary hospitals that host both intensive care units (ICUs) and active maternity/postpartum services. Data collection will integrate three parallel streams: (1) continuous EEG monitoring in selected ICU patients at high risk of death, (2) systematic mapping of postpartum‑related human traffic (staff and visitors), and (3) environmental olfactory sampling to quantify postpartum‑associated odor markers.
Participants
ICU Patients
- Inclusion criteria
- Adult patients (≥18 years) admitted to medical or surgical ICUs.
- Undergoing continuous EEG monitoring for clinical reasons (e.g., coma, post‑cardiac arrest care, refractory seizures, or neurocritical care).
- High risk of in‑hospital death as judged by the treating team (e.g., severe brain injury, refractory shock, post‑anoxic coma).
- Exclusion criteria
- Pre‑existing conditions that severely distort or invalidate EEG interpretation (e.g., extensive skull defects, implanted electrical devices causing artifact).
- Patients for whom research consent (from patient or surrogate) cannot be obtained according to local regulations.
Staff and Visitors
- All ICU staff members and hospital staff who enter the ICU during the study period will be eligible for inclusion in the olfactory‑exposure mapping, with minimal demographic data collected (e.g., role, primary ward assignment).
- Visitors to ICU patients will be logged with respect to recent contact with maternity/postpartum wards or newborns, without collecting identifiable personal health information.
Definition of the “Postpartum Olfactory Field”
For the purposes of this study, the postpartum olfactory field is defined as the combination of:
- Physical presence in the ICU of individuals who have had close contact with a postpartum woman or newborn in the previous 24 hours (including partners, relatives, postpartum staff, and maternity‑ward staff rotating through the ICU).
- Measurable air‑borne volatile organic compounds (VOCs) and molecular markers associated with human breast milk, lochia, and maternal body odor in the ICU environment.
Data Collection Procedures
1. Continuous EEG Monitoring
- ICU patients meeting inclusion criteria will undergo continuous EEG according to standard clinical protocols (e.g., 21‑channel scalp EEG, sampled at ≥256 Hz).
- EEG recording will continue as long as clinically indicated, including any transition to death or formal determination of brain death when it occurs during monitoring.
- Time of death or time of brain‑death determination will be precisely logged. When possible, a symmetric window around the terminal event (e.g., 30–60 seconds before and after the final organized cardiac activity or the last identifiable cortical activity) will be marked for detailed analysis.
2. Mapping Postpartum‑Related Human Traffic
A brief standardized log will be maintained at ICU entry points and electronically linked to time stamps:
- Staff log
- Role (e.g., ICU nurse, anesthesiologist, obstetrician, midwife).
- Primary ward in the preceding 24 hours (e.g., ICU, maternity, postpartum, NICU, mixed).
- Self‑reported close contact with a postpartum woman or newborn within the last 24 hours (yes/no; approximate duration).
- Visitor log
- Relationship to any patient in the hospital (e.g., partner of a recent mother, parent/grandparent of a newborn, relative of an ICU patient only).
- Visits to maternity/postpartum or neonatal units in the last 24 hours (yes/no).
- Self‑reported physical closeness to a newborn or postpartum mother (e.g., holding, hugging, skin‑to‑skin, being in the same room).
These logs will be converted into a Postpartum Contact Index (PCI) for each hour of the study period in each ICU, reflecting the density and intensity of postpartum‑exposed individuals present in the unit.
3. Environmental Olfactory Sampling
- Air samples will be collected in predefined ICU locations (e.g., central nursing station, representative patient rooms) at regular intervals (e.g., every 4–6 hours) using standard VOC sampling devices and sorbent tubes.
- Target analytes will include known components of human breast milk and maternal/neonatal body odor (e.g., selected short‑ and medium‑chain fatty acids, specific aldehydes and ketones, and other candidate biomarkers identified from prior maternal odor studies).
- Samples will be stored and later analyzed by gas chromatography–mass spectrometry (GC–MS) or equivalent techniques.
- For each time block, an Olfactory Marker Index (OMI) will be computed, representing the concentration and combination of postpartum‑associated odor markers in ICU air.
Exposure Classification
For each ICU patient and each hour of EEG recording, a combined Postpartum Olfactory Exposure Score (POES) will be calculated by integrating:
- The Postpartum Contact Index (PCI) for that hour in the patient’s ICU, and
- The Olfactory Marker Index (OMI) for the nearest spatial sampling point and time window.
POES will be treated both as a continuous variable and as a categorical exposure (e.g., low, medium, high) based on predefined thresholds.
EEG Analysis
Pre‑processing
- Raw EEG data will be filtered to remove line noise and artifacts according to standard neurophysiology practice.
- Epochs containing overwhelming artifact (e.g., severe movement or electrical interference not related to physiology) will be excluded.
Identification of Life‑Recall–Like Patterns
- Time–frequency analyses (e.g., wavelet or short‑time Fourier transform) will be applied to windows surrounding the terminal period (e.g., −300 to +120 seconds relative to death or last organized EEG activity).
- A priori criteria for life‑recall–like EEG events will include:
- Brief (e.g., 10–30 seconds) increases in coordinated high‑frequency (gamma‑band) power in frontal, temporal, and/or parietal regions.
- Increased phase synchrony or coherence between regions implicated in autobiographical memory (e.g., frontal–temporal and frontal–parietal networks).
- These features will be defined based on previous case reports and pilot analyses and will be validated by blinded neurophysiologists who are unaware of the POES classification.
Outcome Measures
- Primary outcome
- Presence or absence of at least one life‑recall–like EEG event in the final 10 minutes of recording before death or brain‑death determination.
- Secondary outcomes
- Number, duration, and amplitude of life‑recall–like events per patient.
- Temporal proximity between peak POES hours and occurrence of such EEG events.
- Dose–response relationship between POES and quantitative gamma‑band measures.
Statistical Analysis
- Descriptive statistics will summarize patient demographics, clinical variables, POES distributions, and EEG outcomes.
- The association between POES (continuous and categorical) and the presence of life‑recall–like EEG patterns will be tested using logistic regression models, adjusting for key confounders (e.g., age, primary diagnosis, sedation level, hypoxia markers).
- Time‑to‑event or time‑locked analyses may be used to examine whether life‑recall–like patterns preferentially occur during or shortly after periods of high POES.
- Sensitivity analyses will exclude patients with major EEG confounds and will explore alternative definitions of exposure windows (e.g., 12‑, 24‑hour cumulative POES before death).
Ethical Considerations
- The study will undergo review and approval by institutional ethics committees.
- For ICU patients, consent will be obtained from the patient or legally authorized representatives where required; in some jurisdictions, waiver or deferred consent may be considered for minimal‑risk observational data that are already collected as part of routine care.
- Staff and visitor logs will collect only minimal, non‑identifiable information focused on exposure patterns; no personal health data from postpartum women or newborns will be recorded.
- Environmental sampling will not alter standard care and will be conducted in accordance with hospital safety policies.
Summary of the Conceptual Mechanism
This protocol operationalizes the idea that a postpartum olfactory field—carried invisibly by staff and visitors and measurable in the ICU air—may act as a biological key that transiently “softens” the adult olfactory bulb geometry at the end of life. By correlating this exposure with the presence of life‑recall–like EEG signatures, the study seeks to determine whether the “million‑fold lock” of the olfactory bulb plays a causal role in the replay of autobiographical memory at the moment of death.
İstersen bir sonraki adımda bu metnin başına çok kısa bir “Abstract” ve sona da tartışma için 2–3 cümlelik “Implications” bölümü yazabilirim; bunu nereye kullanmayı planlıyorsun (makale mi, proje başvurusu mu)?
Bir yanıt yazın